CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Microgravity R&D
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Orion and Oriola to continue partnership in Finland

Orion and Oriola are renewing their distribution agreement in Finland. According to the agreement, Oriola will continue to provide warehousing and distribution services for Orion’s human and veterinary pharmaceuticals in Finland. The new agreement was signed on 29 June 2023, and is effective from 1 July 2024.


The close cooperation of the two Finnish companies will continue to secure quality and timely distribution of pharmaceuticals to the Finnish healthcare sector.


“I’m very pleased with the continuation of our partnership. Oriola and Orion have a long history of working together. As companies we share mutual ambition in enhancing the wellbeing of people, animals and society, as well as strong commitment in promoting sustainability in our operations. This requires strong collaboration in the changing healthcare environment,” says Katarina Gabrielson, CEO of Oriola.


“We are happy to continue our long term cooperation with Oriola in ensuring high-quality delivery services to our customers,” says Janne Maksimainen, Head of Region Finland & Baltics at Orion.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    Veracyte, Inc [NASDAQ: VCYT]

    Leveraging Genomics for Personalised Healthcare

    Martin Bostrup, Executive Director, Market Access & Medical Affairs, EMEA

  • Willis Towers Watson

    Alvotech [NASDAQ: ALVO]

    Adopting Blockchain Technology for Clinical Trial Management

    Tomaz Vaupotic, Senior Director, Head of Clinical & Medical Quality

  • Willis Towers Watson

    Novo Nordisk [CPH: NOVO-B]

    Real-World Evidence Empowering Patient-Focused Medical Affairs

    Jesper Lekdorf, VP Global Medical Affairs

  • Willis Towers Watson

    Recordati S.p.A [BIT: REC]

    Navigating Through Drug Discovery and Development

    Stefano Biondi, VP of Pre-Clinical

{literal}{/literal}
Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesrevieweurope.com/news/orion-and-oriola-to-continue-partnership-in-finland-pnid-22.html